EMEA-000368-PIP01-08

Key facts

Active substance
  • travoprost
  • brinzolamide
Therapeutic area
Ophthalmology
Decision number
P/130/2008
PIP number
EMEA-000368-PIP01-08
Pharmaceutical form(s)
suspension
Condition(s) / indication(s)
  • Treatment of glaucoma
  • Treatment of ocular hypertension
Route(s) of administration
Eye drops
Contact for public enquiries
Alcon Laboratories (UK) Ltd.
Doug.MacHatton@AlconLabs.com
United States
Phone: +1 8175518974
Fax: +1 8176154607
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating